Clinical Trial Update: Rituximab in the Treatment of Scleritis and Non-Infectious Orbital Inflammation [Phase 1, Phase 2]

View source ↗

Summary

This document summarizes a Phase 1/2 trial of rituximab for scleritis and non-infectious orbital inflammatory disease, which has completed enrollment and posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Orbital Inflammatory Disease
• Scleritis

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Oregon Health and Science University | Conditions: Scleritis, Orbital Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2013-08-08